Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04761679 · ClinicalTrials.gov registry record · NA
Nasal Bridge Pressure Injury Prevention
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04761679 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 12 participants.
The verdict
NCT04761679, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The primary goal of this study is to explore whether applying the Mepilex foam on the nasal bridge directly between the skin and the N95 mask will prevent nasal bridge pressure injury among nursing staff, secondary to long-term ( \>8+ hours) wear time. The secondary goal is to evaluate if using the Mepilex maintains the seal of the mask.
Interventions
- BEHAVIORAL Applying the Mepilex foam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-03-23 |
| Est. Completion | 2022-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04761679
The ClinicalTrials.gov registry entry for NCT04761679 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Applying the Mepilex foam is the first listed.
NCT04761679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04761679 about?
NCT04761679 is a clinical study titled "Nasal Bridge Pressure Injury Prevention". The primary goal of this study is to explore whether applying the Mepilex foam on the nasal bridge directly between the skin and the N95 mask will prevent nasal bridge pressure injury among nursing staff, secondary to long-term ( \>8+ hours) wear time. The secondary goal is to evaluate if using the ...
What is the current status of trial NCT04761679?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2021-03-23. Estimated completion is 2022-01-04.
What interventions are being tested in trial NCT04761679?
The interventions under investigation include: Applying the Mepilex foam (BEHAVIORAL).
Who is sponsoring clinical trial NCT04761679?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.